Y Care 180 Tablet

Introduction

Y Care is a prescription medication that contains the active ingredient Fexofenadine. It is available under the brand name Y Care. This medication is primarily used for the treatment of allergies, including seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (chronic hives).

Uses

Y Care is prescribed to relieve symptoms associated with allergies, such as sneezing, itching, runny nose, and watery eyes. It is also effective in reducing the occurrence and severity of hives and itching caused by chronic idiopathic urticaria.

Dosage and Administration

The recommended dosage of Y Care may vary depending on the individual’s age, condition, and response to treatment. Follow the instructions provided by your healthcare professional or the medication label. Generally, adults and children above 12 years of age are advised to take one tablet (typically 60 mg) once daily, with or without food. For children aged 6 to 11 years, the recommended dosage is half a tablet (typically 30 mg) once daily.

Mechanism of Action

Y Care contains Fexofenadine, which is an antihistamine. It works by blocking the action of histamine, a natural substance produced by the body during an allergic reaction. By blocking histamine, Fexofenadine helps relieve allergy symptoms, such as sneezing, itching, runny nose, and watery eyes.

Side Effects

Common side effects may include headache, drowsiness, dizziness, and dry mouth. These side effects are usually mild and temporary.

In rare cases, some individuals may experience serious side effects such as difficulty breathing, chest tightness, fast or irregular heartbeat, or severe allergic reactions. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Certain medications may interact with Y Care and may affect its effectiveness or increase the risk of side effects.

Common medications that may interact with Y Care include ketoconazole, erythromycin, and antacids containing aluminum or magnesium. These medications may affect the absorption or metabolism of Y Care. It is advisable to consult your healthcare professional before starting or stopping any medication while using Y Care.

Precautions

Before taking Y Care, inform your healthcare professional about any existing medical conditions, especially if you have kidney problems or are pregnant or breastfeeding. This medication should be used with caution in these situations.

Y Care may cause drowsiness or dizziness. Avoid activities that require mental alertness, such as driving or operating machinery, until you know how this medication affects you.

Storage

Patient Tips

• Take Y Care exactly as prescribed by your healthcare professional.
• If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid consuming grapefruit or grapefruit juice while taking Y Care, as it may interact with the medication.
• If you experience any unusual or persistent symptoms while taking Y Care, contact your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Fexofenadine: antihistamine that relieves allergy symptoms (NHS UK) [Accessed 23 Jun. 2024] (online) Available at:
• Allevia 120mg tablets (Health Professionals SmPC) Available at:
• Fexofenadine (Drugs.com) [Accessed 9 Jun. 2024] (online) Available at:
• fexofenadine hcl (RX/OTC) [Accessed 0 Jun. 2024] (online) Available at:
• Fexofenadine and Pseudoephedrine (MedlinePlus) [Accessed 10 Jun. 2024] (online) Available at:
• Markham A, Wagstaff AJ. Fexofenadine. Drugs. 1998 Feb;55(2):269-74; discussion 275-6. doi: 10.2165/00003495-199855020-00012. [Accessed 9 Jun. 2024] Available at: